Literature DB >> 13864762

Intravenous administration of human gamma-globulin.

S BARANDUN, P KISTLER, F JEUNET, H ISLIKER.   

Abstract

Entities:  

Keywords:  GAMMA GLOBULIN/toxicology

Mesh：

Substances：

Year:  1962        PMID： 13864762     DOI： 10.1111/j.1423-0410.1962.tb03240.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  56 in total

Review 1.  Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.

Authors:  P P Sanna; D R Burton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies.

Authors:  Melvin Berger
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.806

3.  [Research on the effect of complement cytolysin on cell metabolism].

Authors:  H FISCHER; C H VOGT; H HERRSCHAFT
Journal:  Klin Wochenschr       Date:  1963-01-01

Review 4.  Newer uses of intravenous immunoglobulins as anti-infective agents.

Authors:  J E Pennington
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 5.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

6.  Immunotherapy for infectious diseases.

Authors:  J E Pennington
Journal:  West J Med       Date:  1990-04

Review 7.  Effects of protein aggregates: an immunologic perspective.

Authors:  Amy S Rosenberg
Journal:  AAPS J       Date:  2006-08-04       Impact factor: 4.009

Review 8.  Basic principles of intravenous immunoglobulin (IVIg) treatment.

Authors:  Martin Stangel; Refik Pul
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 9.  B cell-targeted therapy for rheumatoid arthritis: an update on the evidence.

Authors:  R John Looney
Journal:  Drugs       Date:  2006       Impact factor: 9.546

10.  Flow Microscopy Imaging Is Sensitive to Characteristics of Subvisible Particles in Peginesatide Formulations Associated With Severe Adverse Reactions.

Authors:  Austin L Daniels; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2018-02-01       Impact factor: 3.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.